← Back to headlines
Morgan Stanley Raises Vertex Pharmaceuticals Price Target
Morgan Stanley has increased its price target for Vertex Pharmaceuticals (VRTX) following updates to its biopharma models.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
1h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
3h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
8h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
8h ago